PARIS–(Business WIRE)–Oct 14, 2020–
Sofinnova Partners, a major European daily life sciences venture money company based in Paris, London and Milan, introduced currently the appointment of Dr. Joe Anderson as Associate in the Sofinnova Crossover Fund, powerful right away.
Dr. Anderson has in excess of 25 years’ practical experience in the healthcare and lifetime sciences industries. Previously, he was a Lover at Abingworth LLP for about a 10 years, the place he led venture-fashion investments in general public firms and the development of the firm’s public equities fund. Most recently, Dr. Anderson was Co-Founder and Chief Executive Officer at Arix Bioscience plc, a enterprise money company shown on the London Inventory Exchange.
Dr. Anderson has considerable expertise as an energetic Board Member establishing revolutionary existence sciences providers in the United kingdom and the US and his investments have included quite a few personal and public financing rounds, IPOs, M&As and exits.
Antoine Papiernik, Chairman and Taking care of Spouse of Sofinnova Associates, commented: “Joe’s arrival signals a decisive minute of expansion for the Sofinnova Crossover Fund. It comes on the heels of a amount of latest milestones, together with two IPOs on the Nasdaq, new investments, good medical details and crucial appointments in our portfolio corporations. His substantial expertise foremost venture cash investments in private and public providers will let us to continue making on the good function of the Crossover staff and positions Sofinnova Partners for even further growth.”
Joe Anderson commented: “I am delighted to be part of Sofinnova Partners at this enjoyable time for daily life sciences in Europe. The business has been a pioneer in existence sciences investing, most not long ago by the founding of the Sofinnova Crossover Fund — just one of the very first of its form in Europe. Record quantities of firms are becoming fashioned from a flourishing science foundation in Europe. Entry to later on-phase scale-up funds is vital as they seek to establish and keep price and the will need for this variety of investment decision has by no means been bigger. I search forward to doing the job with my colleagues to more acquire this primary European approach.”
Jacques Theurillat, Husband or wife in the Sofinnova Crossover Fund, commented: “We warmly welcome Joe to the Sofinnova Crossover crew. Joe’s expertise and abilities will more boost our seasoned group of expense associates, Kinam Hong, Cédric Moreau, Tom Burt and myself, as we help floor-breaking innovations and permit later on-stage lifetime sciences providers to arrive at their complete likely.”
Dr. Anderson commenced his job at the Ciba (now Novartis) Basis, ahead of joining The Wellcome Belief in 1990 in which he turned Head of the approach team. He then moved to the City as a prescription drugs analyst at Dresdner Kleinwort Benson, in advance of being appointed Head of International Health care and Portfolio Supervisor at Initially State Investments, Commonwealth Lender of Australia, in London. He then joined Abingworth LLP as a Associate for 12 a long time before moving on to co-uncovered Arix Biosciences in 2016 and guide its IPO on the London Stock Exchange the adhering to year. He retains a Ph.D. in Biochemistry.
Sofinnova Companions is a top European undertaking capital agency specialized in Everyday living Sciences. Centered in Paris, London and Milan, the business brings jointly a workforce of above 40 specialists from all in excess of Europe, the U.S. and Asia. The organization focuses on paradigm-shifting technologies together with visionary business people. Sofinnova Associates invests across the Daily life Sciences benefit chain as a guide or cornerstone investor, from extremely early-phase options to late-stage/community companies. It has backed 500 corporations more than 48 several years, developing marketplace leaders all around the world. Today, Sofinnova Partners has in excess of €2 billion underneath administration. For a lot more information, please go to: www.sofinnovapartners.com
Head of Communications, Sofinnova Companions
+33 () 6 47 71 38 11North America
+33 () 6 03 35 92 05Italy
Business Keyword: Professional Products and services Overall health FINANCE Analysis SCIENCE BIOTECHNOLOGY
Supply: Sofinnova Associates
Copyright Company Wire 2020.
PUB: 10/14/2020 02:00 AM/DISC: 10/14/2020 02:01 AM
Copyright Enterprise Wire 2020.